Invention Grant
- Patent Title: Herpes simplex virus vaccine
-
Application No.: US14403397Application Date: 2013-05-16
-
Publication No.: US09676824B2Publication Date: 2017-06-13
- Inventor: Lisa Wei , Douglas E. Brough , Christopher Lazarski
- Applicant: GenVec, Inc.
- Applicant Address: US MD Gaithersburg
- Assignee: GenVec, Inc.
- Current Assignee: GenVec, Inc.
- Current Assignee Address: US MD Gaithersburg
- Agency: Leydig, Voit & Mayer, Ltd.
- International Application: PCT/US2013/041358 WO 20130516
- International Announcement: WO2013/180967 WO 20131205
- Main IPC: C07K14/005
- IPC: C07K14/005 ; A61K39/12 ; C12N7/00 ; A61K39/245 ; A61K39/00
Abstract:
Herpes Simplex Virus (HSV) antigens that elicit an HSV-specific immune response and can be used to treat or prevent HSV infection are provided. Nucleic acid sequences, polypeptides, vectors, and compositions, as well as methods to induce an immune response against HSV, treat or prevent HSV disease, induce a T cell response against HSV, and induce an antibody response against HSV also are provided.
Public/Granted literature
- US20150140025A1 HERPES SIMPLEX VIRUS VACCINE Public/Granted day:2015-05-21
Information query
